Bacteria worldwide are becoming more and more resistant to antibiotics: last-resort antibiotics are becoming ineffective. This is a major worldwide threat both to human health and to the animals we depend on. Bacteria like carbapenem-resistant Acinetobacter baumannii and Pseudomonas aeruginosa head the WHO global pathogen priority list. New strategies and treatments are desperately needed.
StraDiVarious is an EU-funded intersectoral network (including large Pharma and SMEs) supporting 15 graduate students around Europe. We focus on emerging bacterial threats. Our goal is to make a difference in the development of next-generation strain-specific rapid diagnostics, and to help find potential drug/vaccine targets.
Learn about our new multiplexed and nanoparticle based approaches to point-of-care rapid pathogen diagnostics.
15 internationally renowned experts from world-class institutions, both academic and industry.
Specialisations in diverse fields of physics, biosciences and medicine.
At the forefront of one of the most pressing global challenges: multidrug-resistant bacteria.
Our team members have collaborated for many years, forming a unique, highly qualified set of supervisors who provide excellent training and research. Our expertise spans patient care, bacterial isolation, genetic and protein analysis, bioinformatics, machine learning, diagnostics, and more. The team also includes both large and small biopharmaceutical companies.
Our H-index average is 40, with values up to 116. We have supervised over 300 PhD students and over 200 PostDocs, publishing more than 2,000 papers in top-tier journals (e.g. Nature, Science, Cell, PNAS, eLife) with over 130,000 citations. Collectively, we hold over 50 patents. Supervisors and former PhD students have received national and international recognition for their groundbreaking contributions. Former PhD students work in the biotech/pharmaceutical industry, in academia, in government and the law. Some have advanced to becoming research heads, professors and CTOs.
.png)
.png)
.png)
.png)
Meet the multidisciplinary team advancing precision medicine to combat antimicrobial resistance through research, diagnostics, and innovative therapeutic strategies.
StraDiVarious will hire 15 PhD students, in EU-speak Doctoral Candidates (DCs). There are no geographical restrictions on where the students can come from, or which of the 15 laboratories they can go to. The only geographical restriction is that you must not be doing a PhD in a country in which you have resided for more than 12 of the previous 36 months at the time of starting your PhD.
We are recruiting 15 fully-funded doctoral candidates for 36-month positions across our European network, with guaranteed secondments in both academic and industrial partner institutions.
.png)
.jpg)
%20(1).png)